Previous studies showed that miR-221/-222 promoted angiogenesis and metastasis in various cancers, including gliomas, colon cancers and breast cancers [33–37] and that c-Myc reduces miR-222 expression in mouse mammary tumors [31]. This evidence concerns the gene MYC and breast cancer.